Literature DB >> 30712984

[Pathologist versus social media: A survival guide].

Charly Liddell1, Aurélien Morini2, Faustine Mittler3, Camille Boulagnon-Rombi4.   

Abstract

Social networks have changed the communication tools among healthcare professionals, enabling instantaneous and globalized sharing and monitoring of information. While more and more pathologists are taking advantage of these tools, some do not yet know them well, or have concerns about their use. These platforms have many advantages and the potential risks can be minimized by appropriate use. A pathologist community is very active, especially on Twitter and Facebook. They share and discuss interesting cases, communicate around our specialty or simply strengthen links between pathologists around the world. Professional organizations and pathology journals are also present. This article aims to present social networks, their pros and cons and to give some good practice tips and examples of uses of the 2 main social networks used in pathology: Facebook and Twitter.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Facebook; Médias/réseaux sociaux; Pathologie; Pathology; Social media/networks; Twitter

Mesh:

Year:  2019        PMID: 30712984     DOI: 10.1016/j.annpat.2018.11.001

Source DB:  PubMed          Journal:  Ann Pathol        ISSN: 0242-6498            Impact factor:   0.407


  2 in total

1.  A remarkable concept of learning in times of educational confinement Social media and pathologist.

Authors:  Sarra Ben Rejeb; Nadia Kouki; Amen Dhaoui; Nizar Jlidi; Khadija Bellil
Journal:  Tunis Med       Date:  2021 Avril

2.  Next-Generation Scholarship: Rebranding Hematopathology Using Twitter: The MD Anderson Experience.

Authors:  Siba El Hussein; Joseph D Khoury; Kirill A Lyapichev; Mehrnoosh Tashakori; Mahsa Khanlari; Roberto N Miranda; Rashmi Kanagal-Shamanna; Sa A Wang; Aadil Ahmed; Kamran M Mirza; Genevieve M Crane; L Jeffrey Medeiros; Sanam Loghavi
Journal:  Mod Pathol       Date:  2020-11-20       Impact factor: 7.842

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.